from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1042c/-

LFCtreatmentdescriptionclass of inhibitor

1.232

Amikacinug/mL Amikacintranslation

0.054

Cap5-10ug/mL Capreomycintranslation

0.005

Rox10-50 ug/mL Roxithromycintranslation

0.146

SM2-5 ug/mL Streptomycintranslation

1.388

Tet5-10 ug/mL Tetracyclinetranslation

-1.092

Rif0.2-5ug/mL Rifampicintranscription

-0.494

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.095

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.466

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.720

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.861

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.008

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.945

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.958

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.358

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.018

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.791

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.427

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.065

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.705

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.276

KCN5-20 ug/mL Potassium cyaniderespiration

0.002

NaN30.2-2 mM Sodium aziderespiration

-1.418

Nigericin50 uM Nigericinrespiration

1.050

TRC10-150 ug/mL Triclosanrespiration

0.577

TRZ10-25 ug/mL Thioridazinerespiration

-0.716

Valinomycin0.5-10 uM Valinomycinrespiration

0.054

ZnSO42 mM ZnSO4respiration

-0.239

menadione6-10 ug/mL Menadionerespiration

-1.081

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.357

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.795

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.559

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.642

NRP_1Non-replicating persistence stage 1dosRassociated

0.261

Amp0.2mg/mL AmpicillincellWall

0.117

Cephalexin20-100 ug/mL CephalexincellWall

-0.736

Cerulenin0.32-5 ug/mL CerulenincellWall

0.184

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.521

EMB10-20 ug/mL EthambutolcellWall

0.187

Eta12-40 ug/mL EthionamidecellWall

0.844

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.106

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.080

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.370

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.197

BZA0.12 mg/mL BenzamidearomaticAmides

0.890

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.899

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.433

H2O24 mM hydrogen peroxideDNAdamaging

0.498

Levo10 ug/mL LevofloxacinDNAdamaging

-0.474

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.070

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.723

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.452

UVUV-irradiationDNAdamaging

-1.307

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.588

Antimycin12.5-50 ug/mL Antimycin A?

0.132

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.893

PA_110-50 ug/mL Antitubercular compound PA-1?

0.450

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.386

PA8240.2-2 ug/mL PA-824?

0.460

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.024

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.461

Verapamil50 uM Verapamil?

-0.334

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.221

methoxatin10-20 ug/mL Methoxatin?